SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: Bill who wrote (194363)1/27/2007 12:05:11 PM
From: Gersh Avery  Respond to of 793926
 
This study was to consider rescheduling the drug. It was run by the DEA. It was a result of a lawsuit filed by Norml in 1972.

Are you trying to say that the study didn't take place?



To: Bill who wrote (194363)1/27/2007 12:21:25 PM
From: Gersh Avery  Respond to of 793926
 
druglibrary.org

Here is the published ruling by the DEA judge.

Please note that the active chemical in marijuana (THC) was rescheduled by the DEA to a schedule III substance.

The DEA now claims that THC is safe, has a low potential for abuse and has little or no street value. .. As long as you call it Marinol.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News